Karyopharm Therapeutics
KPTI
KPTI
168 hedge funds and large institutions have $987M invested in Karyopharm Therapeutics in 2020 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 61 increasing their positions, 44 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
4% more capital invested
Capital invested by funds: $949M → $987M (+$38.7M)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
0.13% less ownership
Funds ownership: 5.91% → 5.78% (-0.13%)
Holders
168
Holding in Top 10
2
Calls
$11.2M
Puts
$7.99M
Top Buyers
| 1 | +$36.1M | |
| 2 | +$12.9M | |
| 3 | +$9.29M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$8.53M |
| 5 |
Alkeon Capital Management
New York
|
+$7.76M |
Top Sellers
| 1 | -$87.6M | |
| 2 | -$19.3M | |
| 3 | -$15.6M | |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$11.6M |
| 5 |
Two Sigma Advisers
New York
|
-$10.5M |